| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| R&D Expense | $55.1M | +17.9% |
| SG&A Expense | $25.8M | -7.8% |
| Operating Income | -$80.9M | -8.3% |
| Income Tax | $0 | — |
| Net Income | -$76.5M | -7.5% |
| EPS (Basic) | -$1.29 | +0.0% |
| EPS (Diluted) | -$1.29 | +0.0% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $57.6M | -56.2% |
| Short-term Investments | $54.4M | — |
| Current Assets | $115.6M | -36.0% |
| Total Assets | $146.6M | -22.8% |
| Current Liabilities | $14.5M | +33.9% |
| Total Liabilities | $40.7M | +135.7% |
| Stockholders' Equity | $106.0M | -38.6% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$67.1M | -12.7% |
| Capital Expenditures | $314K | -75.2% |
| Investing Cash Flow | -$9.8M | -122.6% |
| Financing Cash Flow | $2.9M | -96.8% |
| Free Cash Flow | -$67.4M | -10.9% |